The Evolving Ms Landscape: Challenges and Opportunities - European Medical Journal
×

Browse

The Evolving Ms Landscape: Challenges and Opportunities

|
Neurology
Download as | PDF
Chairpeople:
Mefkûre Eraksoy1
Speakers:
Mefkûre Eraksoy,1 Matthias Mäurer,2 Alastair Compston3
Disclosure:

Prof Eraksoy has received honoraria, educational grants, and consults from: Biogen, Teva Turkey, Gen Pharma, Bayer Healthcare, Merck Serono, Novartis, and Genzyme. Prof Mäurer has received honoraria, travel grants, and speaker fees from: Biogen Idec, Novartis, Teva, Genzyme, Merck Serono, Boehringer, and Bayer. Prof Compston is a scientific adviser to Lundbeck and has received lecture fees (on behalf of himself and the University of Cambridge); Cambridge University has received endowment for a senior academic position from Genzyme.

Acknowledgements:

Writing assistance provided by Dr Tom Priddle.

Support:

The publication of this article was funded by Genzyme. The views and opinions expressed are those of the authors and not necessarily of Genzyme.

Citation
EMJ Neurol. ;1[1]:36-42.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Please view the full content in the pdf above.